Genomic Surveillance of Carbapenem-Resistant Klebsiella pneumoniae in a Tertiary Hospital: A Targeted Snapshot of High-Risk Clones

Introduction: Antimicrobial resistance (AMR) and healthcare-associated infections (HAIs) are major global health threats. This study investigated the genomic landscape and clonal diversity in a targeted hospital-based dataset using whole-genome sequencing (WGS). Methods: Carbapenemase-producing K. pneumoniae isolates exhibiting resistance or reduced susceptibility to carbapenems, comprising infection isolates and selected rectal surveillance swabs were collected between March 2023 and March 2025. Isolates were subjected to WGS using the Illumina NovaSeq X Plus platform, followed by bioinformatic analyses with Galaxy. Phylogenetic relationships were inferred through core-genome alignment and high-resolution SNP analysis. Results: Within the targeted sequenced dataset, the most frequently detected lineages were ST512 (43.3%) and ST147 (30.0%). Phylogenetic analysis revealed high genomic relatedness and temporal persistence of ST512, whereas ST147 and ST2442 showed greater genetic diversity. Phenotypic resistance exceeded 80% for carbapenems and fluoroquinolones. The resistome was characterized by a high prevalence of blaSHV, blaKPC-3 (73.3%), and blaOXA-9 (66.7%), frequently co-occurring. The blaNDM-1 gene was detected in 20% of sequenced isolates; because NDM-positive surveillance isolates were deliberately enriched, this proportion should not be interpreted as hospital-wide prevalence, mainly within ST2442 and ST5859, indicating increasing enzymatic diversity and a shift from a predominantly KPC-driven epidemiology to a more heterogeneous carbapenemase landscape. Conclusion: Genomically related MDR K. pneumoniae isolates were recovered from several hospital wards; however, genomic relatedness alone does not establish direct transmission routes. The identification of blaNDM-1 alongside blaKPC-3 highlights an evolving, increasingly complex carbapenemase landscape. This study offers a targeted genomic snapshot of selected high-risk clones and emerging resistance determinants, providing actionable data to support institutional infection prevention and control (IPC) protocols and antimicrobial stewardship.

Authors

Institutions

Publication Details

Journal
Diseases
Published
2026-11-19
DOI
https://doi.org/10.3390/diseases14110432
Primary Topic
Antibiotic Resistance in Bacteria
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Genomic Surveillance of Carbapenem-Resistant Klebsiella pneumoniae in a Tertiary Hospital: A Targeted Snapshot of High-Risk Clones

Paolo Castiglia, Marco Dettori, Alessandra Palmieri, Narcisa Muresu et al.
Diseases
Antibiotic Resistance in Bacteria
article

Genomic Surveillance of Carbapenem-Resistant Klebsiella pneumoniae in a Tertiary Hospital: A Targeted Snapshot of High-Risk Clones

Paolo Castiglia, Marco Dettori, Alessandra Palmieri, Narcisa Muresu, Antonella Arghittu, Andrea Fausto Piana, Andrea Cossu, Irene Ennas, on behalf of the EDAS Working Group
article en

Abstract

Introduction: Antimicrobial resistance (AMR) and healthcare-associated infections (HAIs) are major global health threats. This study investigated the genomic landscape and clonal diversity in a targeted hospital-based dataset using whole-genome sequencing (WGS). Methods: Carbapenemase-producing K. pneumoniae isolates exhibiting resistance or reduced susceptibility to carbapenems, comprising infection isolates and selected rectal surveillance swabs were collected between March 2023 and March 2025. Isolates were subjected to WGS using the Illumina NovaSeq X Plus platform, followed by bioinformatic analyses with Galaxy. Phylogenetic relationships were inferred through core-genome alignment and high-resolution SNP analysis. Results: Within the targeted sequenced dataset, the most frequently detected lineages were ST512 (43.3%) and ST147 (30.0%). Phylogenetic analysis revealed high genomic relatedness and temporal persistence of ST512, whereas ST147 and ST2442 showed greater genetic diversity. Phenotypic resistance exceeded 80% for carbapenems and fluoroquinolones. The resistome was characterized by a high prevalence of blaSHV, blaKPC-3 (73.3%), and blaOXA-9 (66.7%), frequently co-occurring. The blaNDM-1 gene was detected in 20% of sequenced isolates; because NDM-positive surveillance isolates were deliberately enriched, this proportion should not be interpreted as hospital-wide prevalence, mainly within ST2442 and ST5859, indicating increasing enzymatic diversity and a shift from a predominantly KPC-driven epidemiology to a more heterogeneous carbapenemase landscape. Conclusion: Genomically related MDR K. pneumoniae isolates were recovered from several hospital wards; however, genomic relatedness alone does not establish direct transmission routes. The identification of blaNDM-1 alongside blaKPC-3 highlights an evolving, increasingly complex carbapenemase landscape. This study offers a targeted genomic snapshot of selected high-risk clones and emerging resistance determinants, providing actionable data to support institutional infection prevention and control (IPC) protocols and antimicrobial stewardship.

DiseasesVol. 14(11)
University of Sassari (IT), Azienda Ospedaliero Universitaria di Sassari (IT)
Antibiotic Resistance in Bacteria
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon